Pharmaq News Center
Demand for vaccination is ever-growing in the Canadian salmon industry, and the country’s producers have made a big shift toward mechanized approaches in getting the job done.
New research on deltamethrin resistance in sea lice could help improve the effectiveness and reduce the costs of treating the global salmon industry’s “billion-dollar problem.”
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
The Covid-19 pandemic has, to some extent, made epidemiologists of all of us. But for microbiologists focused on pathogens that don’t affect humans, it has created some new challenges.
The key to the continued growth of the pangasius industry is being more innovative in solving its main fish health, quality and sustainability challenges.
An interview with Danielle Zanerato Damasceno, Technical and Commercial Manager, PHARMAQ Brazil
New measures introduced on fish farms to limit the spread of Covid-19 are fast-tracking the adoption of vaccine machinery as a growing number of producers recognize its advantages.